Pharyngitis Treatment Global Market Report 2024

Pharyngitis Treatment Global Market Report 2024 – By Drug Class (Beta Lactams, Macrolides, Cephalosporins, Fluoroquinolones, Tetracycline, Other Drug Classes), By Source of Infection (Viral, Bacterial), By Modes Of Delivery (Oral, Intravenous, Intramuscular, Other Modes Of Delivery), By End-Users (Hospitals, Homecare, Specialty Centers, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $5000.00 | Pages : 175 | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Pharyngitis Treatment Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Pharyngitis Treatment Market Definition And Segments

Pharyngitis treatment refers to the management and care provided to individuals experiencing inflammation of the mucous membranes of the oropharynx, commonly known as the throat. Pharyngitis can be caused by a variety of reasons, including bacterial or viral infections, allergies, trauma, malignancy, reflux, and some poisons.

The main drug class types of pharyngitis treatment are beta-lactams, macrolides, cephalosporins, fluoroquinolones, tetracycline and others. Beta-lactams are a class of antibiotics that contain a beta-lactam ring in their chemical structure. The various source of infection includes viral and bacterial. The various modes of delivery include oral, intravenous, intramuscular and others that are used by various end-users such as hospitals, homecare, specialty centers and others.

The pharyngitis treatment market covered in this report is segmented –

1) By Drug Class: Beta Lactams, Macrolides, Cephalosporins, Fluoroquinolones, Tetracycline, Other Drug Classes

2) By Source of Infection: Viral, Bacterial

3) By Modes Of Delivery: Oral, Intravenous, Intramuscular, Other Modes Of Delivery

4) By End-Users: Hospitals, Homecare, Specialty Centers, Other End-Users

The pharyngitis treatment market size has grown strongly in recent years. It will grow from $2.15 billion in 2023 to $2.27 billion in 2024 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to high prevalence and growing incidence of flu, rising prevalence of pharyngitis, growing awareness of pharyngitis, increasing access to healthcare, rising disposable incomes.

The pharyngitis treatment market size is expected to see strong growth in the next few years. It will grow to $2.8 billion in 2028 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to adoption of rapid point-of-care tests, demand for personalized medicine, prevalence of antibiotic resistance, rising importance of hand hygiene. Major trends in the forecast period include advancements in research and development of pharyngitis therapies, digital health technologies, telehealth integration, .

Increasing Strep Throat Transmission Fueling Growth In The Pharyngitis Treatment Market

The rising transmission of strep throat is expected to propel the growth of the pharyngitis treatment market going forward. Strep throat is a contagious bacterial infection that primarily affects the throat and tonsils. Prompt and effective treatment of strep throat with antibiotics helps alleviate symptoms, prevent complications and reduce the risk of spreading the infection to others. For instance, in June 2022, according to the Centers for Disease Control and Prevention, a US-based government agency, every year, approximately 14,000 to 25,000 cases of invasive group A strep disease occur in the United States. Additionally, strep diseases lead to 5.2 million outpatient visits and 2.8 million antibiotic prescriptions annually. Therefore, the rising transmission of strep throat drives the pharyngitis treatment market.

Increasing Cases Of Influenza Drive Pharyngitis Treatment Market

The growing incidence of influenza is expected to propel the growth of the pharyngitis treatment market going forward. Influenza, commonly known as the flu, is a contagious respiratory illness caused by influenza viruses. Pharyngitis treatment is primarily used to treat influenza and is helpful for the flu by relieving the symptoms, which are inflammation or irritation, and this treatment focused on relieving allergies and preventing complications such as pneumonia and bronchitis. For instance, in May 2023, according to a report published by the Centers for Disease Control and Prevention (CDC), a US-based government agency, in US there were 9 million flu (influenza) cases in between 2021 and 2022 and 5,000 deaths recorded. Therefore, the growing incidence is driving the growth of the pharyngitis treatment market.

Major players in the pharyngitis treatment market are Pfizer Inc., GlaxoSmithKline PLC, Genentech Inc., Pliva Hrvatska D.o.o., Viatris Inc., Teva Pharmaceutical Industries Ltd., AbbVie Inc., Medtronic PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Fresenius Kabi AG, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, Lupin Limited, Pliva Hrvatska D.o.o., LivaNova PLC, Genentech Inc.

Impact Of Non-Compliance On The Pharyngitis Treatment Market

The impact of patient compliance is restraining the growth of the pharyngitis treatment market during the forecast period. Patients' recovery from pharyngitis may be delayed if they do not comply to specified treatment regimens, resulting in extended sickness. This might cause further discomfort and difficulty, leaving patients dissatisfied with the therapy and perhaps leading to unfavorable word-of-mouth recommendations. For instance, in 2022, according to the BMJ Publishing Group Ltd., a UK-based publisher, about 30% to 50% of people with chronic diseases are thought to not take their medicine as prescribed. Therefore, the impact of patient compliance is hindering the growth of the pharyngitis treatment market.

Evolution Of Sore Throat Relief With Consumer-Focused Treatment Solutions

Major companies operating in the pharyngitis treatment market are introducing innovative products to sustain their position in the market. For instance, in November 2021, RB Health (US) LLC, a US-based pharmaceutical company, launched Mucinex InstaSoothe, a new product line featuring lozenges and sprays designed to numb, soothe and relieve sore throat pain, also known as pharyngitis. The new product line includes clinically proven sore throat and soothing comfort lozenges, sore throat and cough relief lozenges and Mucinex Instasoothe sore throat and pain relief spray. These lozenges are formulated with natural honey and 2.4 mg of hexylresorcinol, providing quick relief for up to 2 hours. The spray also contains benzocaine and menthol, temporarily relieving pain and soothing the throat.

Verfora's Strategic Acquisition Of Spagyros Expands Its Footprint In Swiss Consumer Healthcare Market

In July 2021, Verfora, a Switzerland-based pharmaceutical company, acquired Spagyros Ltd. for an undisclosed amount. With this acquisition, Verfora aims to strengthen pharmacies and drugstores by adding a range of products requiring intensive consultation, enhancing the company's position in the Swiss consumer healthcare market. Spagyros Ltd. is a Switzerland-based manufacturer of phytotherapy and complementary medicines, including sore throat treatment medicines.

North America was the largest region in the pharyngitis treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pharyngitis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pharyngitis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharyngitis treatment market consists of sales of antibiotics, antiviral drugs and antifungal medications. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The pharyngitis treatment market research report is one of a series of new reports from The Business Research Company that provides pharyngitis treatment market statistics, including pharyngitis treatment industry global market size, regional shares, competitors with a pharyngitis treatment market share, detailed pharyngitis treatment market segments, market trends and opportunities and any further data you may need to thrive in the pharyngitis treatment industry. This pharyngitis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Pharyngitis Treatment Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $2.27 billion
Revenue Forecast In 2033 $2.8 billion
Growth Rate CAGR of 5.3% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Drug Class: Beta Lactams, Macrolides, Cephalosporins, Fluoroquinolones, Tetracycline, Other Drug Classes
2) By Source of Infection: Viral, Bacterial
3) By Modes Of Delivery: Oral, Intravenous, Intramuscular, Other Modes Of Delivery
4) By End-Users: Hospitals, Homecare, Specialty Centers, Other End-Users
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled Pfizer Inc.; GlaxoSmithKline PLC; Genentech Inc.; Pliva Hrvatska D.o.o.; Viatris Inc.; Teva Pharmaceutical Industries Ltd.; AbbVie Inc.; Medtronic plc; Takeda Pharmaceutical Company Limited; Eli Lilly and Company; Gilead Sciences Inc.; Amgen Inc.; Boehringer Ingelheim International GmbH; Viatris Inc.; Teva Pharmaceutical Industries Ltd.; Fresenius Kabi AG; Bausch Health Companies Inc.; Sun Pharmaceutical Industries Ltd.; Dr. Reddy's Laboratories Ltd.; Cipla Limited; Hikma Pharmaceuticals plc; Lupin Limited; Pliva Hrvatska D.o.o.; LivaNova PLC; Genentech Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Pharyngitis Treatment Market Characteristics

    3. Pharyngitis Treatment Market Trends And Strategies

    4. Pharyngitis Treatment Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Pharyngitis Treatment Market Size and Growth

    5.1. Global Pharyngitis Treatment Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Pharyngitis Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Pharyngitis Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Pharyngitis Treatment Market Segmentation

    6.1. Global Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Beta Lactams

    Macrolides

    Cephalosporins

    Fluoroquinolones

    Tetracycline

    Other Drug Classes

    6.2. Global Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Viral

    Bacterial

    6.3. Global Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Oral

    Intravenous

    Intramuscular

    Other Modes Of Delivery

    6.4. Global Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospitals

    Homecare

    Speciality Centres

    Other End-Users

    7. Pharyngitis Treatment Market Regional And Country Analysis

    7.1. Global Pharyngitis Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Pharyngitis Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Pharyngitis Treatment Market  

    8.1. Asia-Pacific Pharyngitis Treatment Market Overview  

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Pharyngitis Treatment Market  

    9.1. China Pharyngitis Treatment Market Overview  

    9.2. China Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Pharyngitis Treatment Market  

    10.1. India Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Pharyngitis Treatment Market  

    11.1. Japan Pharyngitis Treatment Market Overview  

    11.2. Japan Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Pharyngitis Treatment Market  

    12.1. Australia Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Pharyngitis Treatment Market  

    13.1. Indonesia Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Pharyngitis Treatment Market  

    14.1. South Korea Pharyngitis Treatment Market Overview  

    14.2. South Korea Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Pharyngitis Treatment Market  

    15.1. Western Europe Pharyngitis Treatment Market Overview

    15.2. Western Europe Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Pharyngitis Treatment Market  

    16.1. UK Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Pharyngitis Treatment Market  

    17.1. Germany Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Pharyngitis Treatment Market  

    18.5. France Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Pharyngitis Treatment Market  

    19.9. Italy Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Pharyngitis Treatment Market  

    20.13. Spain Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Pharyngitis Treatment Market  

    21.1. Eastern Europe Pharyngitis Treatment Market Overview

    21.2. Eastern Europe Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Pharyngitis Treatment Market  

    22.1. Russia Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Pharyngitis Treatment Market  

    23.1. North America Pharyngitis Treatment Market Overview

    23.2. North America Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Pharyngitis Treatment Market  

    24.1. USA Pharyngitis Treatment Market Overview

    24.2. USA Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Pharyngitis Treatment Market  

    25.1. Canada Pharyngitis Treatment Market Overview

    25.2. Canada Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Pharyngitis Treatment Market  

    26.1. South America Pharyngitis Treatment Market Overview

    26.2. South America Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Pharyngitis Treatment Market  

    27.1. Brazil Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Pharyngitis Treatment Market  

    28.1. Middle East Pharyngitis Treatment Market Overview

    28.2. Middle East Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Pharyngitis Treatment Market  

    29.1. Africa Pharyngitis Treatment Market Overview

    29.2. Africa Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Pharyngitis Treatment Market Competitive Landscape And Company Profiles

    30.1. Pharyngitis Treatment Market Competitive Landscape

    30.2. Pharyngitis Treatment Market Company Profiles

    30.2.1. Pfizer Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. GlaxoSmithKline PLC

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Genentech Inc.

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Pliva Hrvatska D.o.o.

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Viatris Inc.

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Pharyngitis Treatment Market Other Major And Innovative Companies

    31.1. Teva Pharmaceutical Industries Ltd.

    31.2. AbbVie Inc.

    31.3. Medtronic plc

    31.4. Takeda Pharmaceutical Company Limited

    31.5. Eli Lilly and Company

    31.6. Gilead Sciences Inc.

    31.7. Amgen Inc.

    31.8. Boehringer Ingelheim International GmbH  

    31.9. Viatris Inc.

    31.10. Teva Pharmaceutical Industries Ltd.

    31.11. Fresenius Kabi AG

    31.12. Bausch Health Companies Inc.

    31.13. Sun Pharmaceutical Industries Ltd.

    31.14. Dr. Reddy's Laboratories Ltd.

    31.15. Cipla Limited

    32. Global Pharyngitis Treatment Market Competitive Benchmarking

    33. Global Pharyngitis Treatment Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Pharyngitis Treatment Market

    35. Pharyngitis Treatment Market Future Outlook and Potential Analysis

    35.1 Pharyngitis Treatment Market In 2028 - Countries Offering Most New Opportunities

    35.2 Pharyngitis Treatment Market In 2028 - Segments Offering Most New Opportunities

    35.3 Pharyngitis Treatment Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Pharyngitis Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global Pharyngitis Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: Pfizer Inc. Financial Performance
  • Table 76: GlaxoSmithKline PLC Financial Performance
  • Table 77: Genentech Inc. Financial Performance
  • Table 78: Pliva Hrvatska D.o.o. Financial Performance
  • Table 79: Viatris Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Pharyngitis Treatment Market, Segmentation By Modes Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Pharyngitis Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global Pharyngitis Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Pharyngitis Treatment Market, Segmentation By Drug Class , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Pharyngitis Treatment Market, Segmentation By Source of Infection, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, Pharyngitis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: Pfizer Inc. Financial Performance
  • Figure 76: GlaxoSmithKline PLC Financial Performance
  • Figure 77: Genentech Inc. Financial Performance
  • Figure 78: Pliva Hrvatska D.o.o. Financial Performance
  • Figure 79: Viatris Inc. Financial Performance
Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis
Read More
How Will The Nuclear Medicine Market Grow In 2022?
Read More
What Is The Pediatric Imaging Market Overview In 2022?
Read More
Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth
Read More
Inflammatory Bowel Disease Treatment Global Market Report 2024 – By Drug Class (Aminosalicylates, Corticosteroids, TNF inhibitors, IL inhibitors, Anti-integrin, JAK inhibitors, Other Drug Classes), By Type (Crohn's Disease, Ulcerative Colitis), By Route of Administration (Oral, Injectable), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Non-Steroidal Anti-inflammatory Drugs Global Market Report 2024 – By Route of Administration( Oral, Topical, Other Route of Administration), By Disease Indication( Arthritis, Migraine, Ophthalmic Diseases, Other Disease Indications), By Distribution Channel( Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Cystic Fibrosis (CF) Therapeutics Global Market Report 2024 – By Drug Class (Pancreatic Enzyme Supplements, Mucolytic, Bronchodilators, CFTR Modulators), By Route Of Administration (Oral, Inhaled), By Treatment Method (Medication, Devices) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Neurodegenerative Disorder Therapeutics Global Market Report 2024 – By Indication Type (Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, Huntington Disease, Other Indication Types), By Drug Type (N- methyl- D- aspartate Receptor, Selective Serotonin Reuptake Inhibitor, Dopamine Inhibitors, Other Drug Types), By Distribution (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Bipolar Disorder Therapeutics Global Market Report 2024 – By Drug Class (Mood Stabilizers, Antipsychotic Drugs, Antidepressant Drugs, Other Drugs), By Mechanism (Selective Serotonin Reuptake Inhibitors, Serotonin-norepinephrine Reuptake Inhibitors, Tricyclic Antidepressants, Monoamine Oxidase Inhibitors, Benzodiazepines, Beta-Blockers, Other Mechanisms), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Digital Therapeutics Global Market Report 2024 – By Product (Software, Devices), By Sales Channel (Business-To-Business (B2B), Business-To-Consumers (B2C)), By Application (Preventive Applications, Treatment Or Care-Related Applications) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Leukemia Therapeutics Global Market Report 2024 – By Treatment Type (Chemotherapy, Immunotherapy, Targeted Therapy, Other Treatments), By Type Of Leukemia (Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia, Other Type Of Leukemia), By Molecule Type (Small Molecules, Biologics), By End-Users (Hospitals, Homecare, Specialty Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Peptide Therapeutics Global Market Report 2024 – By Type (Generic, Branded), By Route of Administration (Parenteral, Mucosal, Oral, Transdermal), By Application (Cancer, Cardiovascular Diseases, Central Nervous Systems, Metabolic Disorders, Infections, Hematological Disorders, Gastrointestinal Disorders, Dermatology, Respiratory Disorders, Acromegaly, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033
View Report

Frequently Asked Questions

What is the definition of the pharyngitis treatment market?

Pharyngitis treatment refers to the management and care provided to individuals experiencing inflammation of the mucous membranes of the oropharynx, commonly known as the throat. Pharyngitis can be caused by a variety of reasons, including bacterial or viral infections, allergies, trauma, malignancy, reflux, and some poisons. request a sample here

How will the pharyngitis treatment market drivers and restraints affect the pharyngitis treatment market dynamics? What forces will shape the pharyngitis treatment industry going forward?

The pharyngitis treatment market major growth driver - Increasing Strep Throat Transmission Fueling Growth In The Pharyngitis Treatment Market. request a sample here

What is the forecast market size or the forecast market value of the pharyngitis treatment market?

The pharyngitis treatment market size has grown strongly in recent years. It will grow from $2.15 billion in 2023 to $2.27 billion in 2024 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to high prevalence and growing incidence of flu, rising prevalence of pharyngitis, growing awareness of pharyngitis, increasing access to healthcare, rising disposable incomes. The pharyngitis treatment market size is expected to see strong growth in the next few years. It will grow to $2.8 billion in 2028 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to adoption of rapid point-of-care tests, demand for personalized medicine, prevalence of antibiotic resistance, rising importance of hand hygiene. Major trends in the forecast period include advancements in research and development of pharyngitis therapies, digital health technologies, telehealth integration, . request a sample here

How is the pharyngitis treatment market segmented?

The pharyngitis treatment market is segmented
1) By Drug Class: Beta Lactams, Macrolides, Cephalosporins, Fluoroquinolones, Tetracycline, Other Drug Classes
2) By Source of Infection: Viral, Bacterial
3) By Modes Of Delivery: Oral, Intravenous, Intramuscular, Other Modes Of Delivery
4) By End-Users: Hospitals, Homecare, Specialty Centers, Other End-UsersFor further insights on the pharyngitis treatment market request a sample here

Which region has the largest share of the pharyngitis treatment market? What are the other regions covered in the report?

North America was the largest region in the pharyngitis treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pharyngitis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. request a sample here.

Who are the major players in the pharyngitis treatment market?

Major players in the pharyngitis treatment market are Pfizer Inc., GlaxoSmithKline PLC, Genentech Inc., Pliva Hrvatska D.o.o., Viatris Inc., Teva Pharmaceutical Industries Ltd., AbbVie Inc., Medtronic PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Fresenius Kabi AG, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, Lupin Limited, Pliva Hrvatska D.o.o., LivaNova PLC, Genentech Inc. request a sample here.

What are the key trends in the pharyngitis treatment market?

Major trend in the pharyngitis treatment market - Evolution Of Sore Throat Relief With Consumer-Focused Treatment Solutions. request a sample here.

What are the major opportunities in the pharyngitis treatment market? What are the strategies for the pharyngitis treatment market?

For detailed insights on the major opportunities and strategies in the pharyngitis treatment market, request a sample here.

How does the pharyngitis treatment market relate to the overall economy and other similar markets?

For detailed insights on pharyngitis treatment market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the pharyngitis treatment industry?

For detailed insights on the mergers and acquisitions in the pharyngitis treatment industry, request a sample here.

What are the key dynamics influencing the pharyngitis treatment market growth? SWOT analysis of the pharyngitis treatment market.

For detailed insights on the key dynamics influencing the pharyngitis treatment market growth and SWOT analysis of the pharyngitis treatment industry, request a sample here.